Jeffrey Dierks, Chief Commercial Officer at Harmony Biosciences Holdings, Inc. (HRMY), sold 19,779 shares at $40.04 ($792K) on 2022-03-01, disclosed to the SEC on 2022-03-02.
Open-market sale of $792k HRMY by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.00 | 10,041 | $402K | 50.7% |
| 2 | $40.04 | 4,869 | $195K | 24.6% |
| 3 | $40.04 | 4,869 | $195K | 24.6% |
| Total | $40.02 avg | 19,779 | $792K | 100% |
| Filing → |
| HRMY | SELL | 2025-01-21 | $2.3M | — | Filing → |
| HRMY | SELL | 2025-01-16 | $778K | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |